Inviting for Articles: Clinical Pathology
The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections. Journal of Clinical & Experimental Pathology covers all areas of clinical and experimental pathology. Articles such as research papers, review articles, commentaries and short communications leading to the development of Journal of clinical and experimental pathology.
The Journal of Clinical and Experimental Pathology Open Access Journal, encourages on-going international research and articles related to but not limited to Medical microbiology, pathogenic microbes, Pathological microbiology (antibiotics, enzymes, vitamins, vaccines) Industrial microbiology, Microbial biotechnology, Plant pathology, Veterinary, Food, Agricultural, Soil, Environmental, Cellular, Cyto, Histo, Dermato, Surgical Pathology etc.
It’s our privilege to recite you as a foremost strategist in the realm of research and invite you to endowment your research penmanship and publication in forth coming issue in the form of Research, Reviews, Commentaries, Letter to Editor, Case Reports, Short Communication, Images, Conference Proceedings which will be published in our journal.
Journal of Clinical and Experimental Pathology brings articles in all areas related to applications of microorganisms that include biotechnology, medicine, Plant pathology, Veterinary, Food, Agricultural, Soil, Environmental, Cellular, Cyto, Histo, Dermato, Surgical Pathology etc.
Publication Ethics and Malpractice Statement
Omics Publishing Policy Regarding the NIH Mandate
Omics Publishing will support authors by posting the published version of articles by NIH grant-holders and European or UK-based biomedical or life sciences grant holders to PubMed Central immediately after publication
Editorial Policies and Process
Journal of Clinical and Experimental Pathology follows a progressive editorial policy that encourages researchers to submit the original research, reviews and editorial observations as articles, well supported by tables and graphic representation.
Submission of an Article
In order to reduce delays, authors should adhere to the level, length and format of the Omics Publishing Journals at every stage of processing right from manuscript submission to each revision stage. Submitted articles should have 300 words summary/abstract, separate from the main text. The summary should provide a brief account of the work by clearly stating the purpose of the study and the methodology adopted, highlighting major findings briefly. The text may contain a few short subheadings of no more than 40 characters each.
With an intention to take scientific & health care information globally, Omics Publishing has introduced language translation services. This service enables the author to reach the global audience in many major world languages at a time as our language experts in Spanish, French and German can translate the article from English into different world languages as per the author’s requirement. This service grants a global presence to the author and his/her scholarship.
Journal of Clinical and Experimental Pathology is using Editorial Tracking System to maintain quality and transparency to the author in the peer-review process. Review processing will be performed by the editorial board members of the Journal of Clinical and Experimental Pathology or by Reviewers (outside experts in the field). Two independent reviewer’s approval (Minimum reviewer’s approval) followed by editor approval is obligatory for acceptance of any manuscript excluding an editorial.
On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.